CD8A and neoplasm: In addition, EC.SENESCENCE.SIG correlates with dysregulated tumor infiltration by CD8+ T cells and M2-polarized tumor-associated macrophages, which is considered a determinant of anti-PD-L1/PD-1 immunotherapy efficacy [59, 60].